Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 20 studies | 31% ± 15% | |
astrocyte | 15 studies | 37% ± 18% | |
microglial cell | 12 studies | 35% ± 12% | |
oligodendrocyte | 12 studies | 30% ± 12% | |
oligodendrocyte precursor cell | 11 studies | 37% ± 15% | |
macrophage | 10 studies | 34% ± 14% | |
fibroblast | 10 studies | 29% ± 13% | |
adipocyte | 9 studies | 28% ± 8% | |
dendritic cell | 9 studies | 35% ± 16% | |
GABAergic neuron | 8 studies | 43% ± 20% | |
B cell | 7 studies | 23% ± 8% | |
natural killer cell | 7 studies | 23% ± 7% | |
myeloid cell | 7 studies | 24% ± 7% | |
glutamatergic neuron | 6 studies | 45% ± 23% | |
interneuron | 6 studies | 44% ± 22% | |
plasmacytoid dendritic cell | 6 studies | 26% ± 7% | |
mast cell | 6 studies | 23% ± 5% | |
endothelial cell of lymphatic vessel | 6 studies | 32% ± 12% | |
CD16-negative, CD56-bright natural killer cell, human | 5 studies | 22% ± 3% | |
epithelial cell | 5 studies | 39% ± 25% | |
T cell | 5 studies | 23% ± 6% | |
monocyte | 5 studies | 34% ± 11% | |
pericyte | 5 studies | 31% ± 13% | |
smooth muscle cell | 5 studies | 28% ± 4% | |
type I pneumocyte | 5 studies | 27% ± 9% | |
type II pneumocyte | 5 studies | 29% ± 7% | |
CD16-positive, CD56-dim natural killer cell, human | 4 studies | 20% ± 5% | |
granule cell | 4 studies | 23% ± 4% | |
neuron | 4 studies | 51% ± 18% | |
naive B cell | 4 studies | 19% ± 2% | |
cardiac muscle cell | 4 studies | 23% ± 2% | |
lymphocyte | 4 studies | 33% ± 14% | |
amacrine cell | 4 studies | 23% ± 8% | |
retinal cone cell | 4 studies | 35% ± 11% | |
retinal rod cell | 4 studies | 30% ± 7% | |
club cell | 4 studies | 30% ± 9% | |
classical monocyte | 3 studies | 23% ± 3% | |
conventional dendritic cell | 3 studies | 30% ± 12% | |
hematopoietic precursor cell | 3 studies | 23% ± 8% | |
non-classical monocyte | 3 studies | 21% ± 4% | |
GABAergic interneuron | 3 studies | 29% ± 8% | |
progenitor cell | 3 studies | 29% ± 4% | |
CD4-positive, alpha-beta T cell | 3 studies | 19% ± 2% | |
vein endothelial cell | 3 studies | 33% ± 20% | |
Mueller cell | 3 studies | 35% ± 12% | |
endothelial cell of vascular tree | 3 studies | 32% ± 19% | |
hepatocyte | 3 studies | 40% ± 17% | |
ependymal cell | 3 studies | 43% ± 13% | |
alveolar macrophage | 3 studies | 37% ± 9% | |
ciliated cell | 3 studies | 25% ± 8% | |
respiratory goblet cell | 3 studies | 30% ± 11% | |
basal cell | 3 studies | 44% ± 29% | |
goblet cell | 3 studies | 38% ± 28% | |
brush cell | 3 studies | 24% ± 3% | |
mesothelial cell | 3 studies | 29% ± 1% | |
mural cell | 3 studies | 32% ± 10% | |
mucus secreting cell | 3 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1439.05 | 1445 / 1445 | 100% | 9.23 | 183 / 183 |
lung | 100% | 1593.38 | 577 / 578 | 100% | 6.96 | 1153 / 1155 |
breast | 100% | 1561.57 | 459 / 459 | 100% | 8.31 | 1114 / 1118 |
bladder | 100% | 1343.00 | 21 / 21 | 99% | 6.01 | 500 / 504 |
prostate | 100% | 1481.26 | 245 / 245 | 99% | 5.06 | 498 / 502 |
thymus | 100% | 1833.15 | 653 / 653 | 99% | 5.37 | 600 / 605 |
pancreas | 100% | 779.75 | 328 / 328 | 99% | 5.12 | 176 / 178 |
uterus | 100% | 1856.39 | 170 / 170 | 98% | 6.84 | 452 / 459 |
stomach | 100% | 977.24 | 359 / 359 | 98% | 5.55 | 281 / 286 |
intestine | 100% | 1398.33 | 966 / 966 | 98% | 4.92 | 515 / 527 |
ovary | 100% | 1716.21 | 180 / 180 | 96% | 2.97 | 412 / 430 |
brain | 96% | 667.00 | 2541 / 2642 | 99% | 5.02 | 701 / 705 |
kidney | 100% | 892.64 | 89 / 89 | 94% | 3.74 | 849 / 901 |
adrenal gland | 100% | 976.74 | 258 / 258 | 94% | 2.55 | 216 / 230 |
skin | 100% | 2054.54 | 1809 / 1809 | 93% | 4.11 | 438 / 472 |
liver | 100% | 680.60 | 226 / 226 | 91% | 2.72 | 370 / 406 |
adipose | 100% | 1521.92 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1303.03 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 6.65 | 29 / 29 |
spleen | 100% | 1469.50 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 6.65 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.80 | 1 / 1 |
muscle | 100% | 874.88 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 741.11 | 838 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 87% | 1114.61 | 808 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 65% | 1.80 | 52 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006337 | Biological process | nucleosome disassembly |
GO_0045815 | Biological process | transcription initiation-coupled chromatin remodeling |
GO_0006334 | Biological process | nucleosome assembly |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0070577 | Molecular function | lysine-acetylated histone binding |
GO_0005524 | Molecular function | ATP binding |
GO_0042393 | Molecular function | histone binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0003682 | Molecular function | chromatin binding |
Gene name | ATAD2B |
Protein name | ATPase family AAA domain containing 2B ATPase family AAA domain-containing protein 2B ATAD2B protein |
Synonyms | KIAA1240 |
Description | |
Accessions | ENST00000458510.1 C9JG15 ENST00000238789.10 [Q9ULI0-1] Q9ULI0 ENST00000439915.1 ENST00000381024.4 H7BYF1 Q8IWJ3 C9J1G9 |